147 related articles for article (PubMed ID: 10475997)
1. The measurement of venous haematocrit in patients with polycythaemia vera.
Andréasson B; Wahlström E; Jacobsson S; Björkholm M; Samuelsson J; Birgegård G; Wadenvik H; Kutti J
J Intern Med; 1999 Sep; 246(3):293-7. PubMed ID: 10475997
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of diagnostic approach to erythrocytosis of different genesis].
Ter Arkh; 2012; 84(4):29-35. PubMed ID: 22774487
[TBL] [Abstract][Full Text] [Related]
3. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.
Johansson P; Safai-Kutti S; Lindstedt G; Suurküla M; Kutti J
Acta Haematol; 2002; 108(1):1-7. PubMed ID: 12145459
[TBL] [Abstract][Full Text] [Related]
4. Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
Andréasson B; Carneskog J; Lindstedt G; Lundberg PA; Swolin B; Wadenvik H; Kutti J
Leuk Lymphoma; 2000 Mar; 37(1-2):189-95. PubMed ID: 10721786
[TBL] [Abstract][Full Text] [Related]
5. Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.
Birgegård G; Wide L
Br J Haematol; 1992 Aug; 81(4):603-6. PubMed ID: 1390249
[TBL] [Abstract][Full Text] [Related]
6. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.
Johansson PL; Safai-Kutti S; Kutti J
Br J Haematol; 2005 Jun; 129(5):701-5. PubMed ID: 15916693
[TBL] [Abstract][Full Text] [Related]
7. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
[TBL] [Abstract][Full Text] [Related]
8. PCV measurement in the management of polycythaemic patients.
Guthrie DL; Pearson TC
Clin Lab Haematol; 1982; 4(3):257-65. PubMed ID: 6756765
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol.
Bhatia S; Kaur P; Kaur G; Tahlan A; Saini V; Bedi R; Mittal K; Sood T
Transfus Clin Biol; 2023 Feb; 30(1):63-68. PubMed ID: 35835318
[TBL] [Abstract][Full Text] [Related]
10. The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera.
Nersesjan V; Zervides KA; Sørensen AL; Kjaer L; Skov V; Hasselbalch HC
Eur J Haematol; 2020 Jan; 104(1):46-54. PubMed ID: 31584701
[TBL] [Abstract][Full Text] [Related]
11. An exceptional case of renal artery restenosis in a patient with polycythaemia vera.
Gavriilaki E; Sampanis N; Kavlakoudis C; Papaioannou G; Vasileiou S
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):904-6. PubMed ID: 24991947
[TBL] [Abstract][Full Text] [Related]
12. Leeching as initial treatment in a cat with polycythaemia vera.
Nett CS; Arnold P; Glaus TM
J Small Anim Pract; 2001 Nov; 42(11):554-6. PubMed ID: 11721985
[TBL] [Abstract][Full Text] [Related]
13. Polycythemia Vera: The Packed Cell Volume and The Curious Logic of The Red Cell Mass.
Fairbanks VF
Hematology; 1999; 4(5):381-95. PubMed ID: 27426842
[TBL] [Abstract][Full Text] [Related]
14. Use of ferrokinetics in the follow-up of patients with polycythaemia vera.
García Y; Callejas J; Hernández P
Haematologia (Budap); 1988; 21(1):41-6. PubMed ID: 3396974
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera.
Stasi R; Brunetti M; Bussa S; Venditti A; Del Poeta G; Conforti M; Scimò MT; Cudillo L; Adorno G; Cecconi M; Amadori S; Pagano A
J Intern Med; 1997 Aug; 242(2):143-7. PubMed ID: 9279291
[TBL] [Abstract][Full Text] [Related]
16. Comparison of diagnostic criteria for polycythaemia vera.
Turkington RC; Arnold EC; Percy MJ; Ranaghan LA; Cuthbert RJ; McMullin MF
Hematology; 2007 Apr; 12(2):123-30. PubMed ID: 17454193
[TBL] [Abstract][Full Text] [Related]
17. Analysis of real-world data demonstrating the efficacy of current management of polycythaemia vera in attaining and maintaining therapeutic haematocrit.
Buckley FD; Arnold C; Brass D; Catherwood M; McMullin MF
Ir J Med Sci; 2024 Apr; 193(2):833-836. PubMed ID: 37682452
[TBL] [Abstract][Full Text] [Related]
18. Histamine metabolism in polycythaemia vera.
Westin J; Granerus G; Weinfeld A; Wetterquist H
Scand J Haematol; 1975 Aug; 15(1):45-57. PubMed ID: 1179164
[TBL] [Abstract][Full Text] [Related]
19. Characterization of blood donors with high haemoglobin concentration.
Magnussen K; Hasselbalch HC; Ullum H; Bjerrum OW
Vox Sang; 2013 Feb; 104(2):110-4. PubMed ID: 22891616
[TBL] [Abstract][Full Text] [Related]
20. Platelet survival in active polycythaemia vera with reference to the haematocrit level. An experimental study before and after phlebotomy.
Kutti J; Weinfeld A
Scand J Haematol; 1971; 8(5):405-14. PubMed ID: 5134837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
